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Background: The genus Flavivirus includes several pathogenic agents that cause severe illness in humans. Re-
emergence of West Nile virus in Europe and continuous spread of certain flaviviruses such as dengue, yellow fever
and Japanese encephalitis viruses represent a global danger to public health. Therefore, a rapid and accurate
molecular method is required for diagnostics and epidemiological surveillance of flaviviruses.
Methods: A Pan-Flavi quantitative RT-PCR assay using a Locked-Nucleic Acid probe targeting the flavivirus NS5
gene was developed and optimized to detect a wide range of flaviviruses simultaneously. The specificity and
sensitivity of the Pan-Flavi assay were tested using RNA of different flaviviruses and non-flaviviruses. Furthermore,
the assay was compared directly to flavivirus species-specific assays for the ability to detect flaviviruses sensitively.
Results: Two degenerate primers and one Locked-Nucleic Acids probe were designed to amplify most of the
flaviviruses. To increase the specificity and fluorescence signal of the Pan-Flavi assay for detection of yellow fever
virus and dengue virus 4, additional primers and probes were included. Viral RNA of thirty different flaviviruses was
detected, verifying the broad range specificity. The testing of this assay was successful, using standard plasmid and
RNA dilutions of yellow fever virus vaccine strain, dengue virus 1 and tick-borne encephalitis virus, with a sensitivity
limit of 10–100 genome copies/reaction. Also comparatively good results were achieved for detecting different
flaviviruses by the Pan-Flavi assay when compared to the flavivirus species-specific assays.
Conclusion: The assay is rapid, broad-range flavivirus-specific and highly sensitive making it a valuable tool for
rapid detection of flaviviruses in livestock samples, epidemiological studies or as useful complement to single
flavivirus-specific assays for clinical diagnosis.
Keywords: Pan-Flavi assay, Locked-nucleic acid, Flaviviruses, qRT-PCRBackground
The genus Flavivirus of the family Flaviviridae consists of
more than 70 virus species including many arthropod-
borne viruses. It contains highly pathogenic agents such
as the name-giving member yellow fever virus (YFV),
West Nile virus (WNV), Japanese encephalitis virus (JEV),
tick-borne encephalitis virus (TBEV) and dengue virus
(DENV), which can cause encephalitis or hemorrhagic* Correspondence: patelp@rki.de
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reproduction in any medium, provided the orfever and pose some of the most challenging emerging
diseases in humans [1].
Flaviviruses comprise three epidemiologically distinct
groups; the mosquito-borne group, the tick-borne group
and the unknown vector viruses [2]. They are enveloped
positive-stranded RNA viruses with a genome of ap-
proximately 11 kb. The viral genome encodes a large
single polyprotein from which three structural proteins,
Capsid (C), Envelope (E) and Membrane (M) and seven
non-structural proteins, NS1, NS2A, NS2B, NS3, NS4A,
NS4B and NS5, are produced [3].
Flaviviruses pose a threat to public health worldwide,
especially in developing countries. In recent years, thered. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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infections globally. The disease is endemic in more than
100 countries in Africa, the Americas, the Eastern Medi-
terranean, South-east Asia, and the Western Pacific.
About 50–100 million cases of DENV infection are
reported worldwide every year, resulting in 500,000 cases
of hemorrhagic fever requiring hospitalization and
25,000 fatalities [4]. Yellow Fever is endemic in 45
countries throughout Africa and Latin America, with
approximately 200,000 cases of human infections
worldwide, and 30,000 mortalities [5]. WNV is one of
the most widespread flaviviruses. WNV lineage 1 is en-
demic in the Americas, India, and Australia. Both
lineages 1 and 2 are found in Africa and Europe [6-8].
The recent WNV outbreak reported in August 2010 in
Greece was the first large outbreak in humans in Europe
since the Romanian outbreak in 1996–1997 [9]. JEV is
the leading cause of viral encephalitis in Asia with
30,000–50,000 clinical cases reported annually and
10,000 deaths [10]. TBEV, virus-causing infection of the
central nervous system, has spread extensively in some
European regions. According to ECDC [11], human
cases of TEBV infections have increased in the past 30
years dramatically posing a danger to public health in
European countries.
A number of flaviviruses have repeatedly demonstrated
their ability to expand their geographical range. Some
current examples are the introduction of Usutu virus and
Bagaza virus into central Europe [12,13], or Zika virus into
Yap island and Cambodia [14]. In recent years, also a high
number of mosquito-only flaviviruses including Culex and
Aedes flaviviruses were discovered throughout the world
[15-18]. Apart from the human pathogenic and mosquito-
only flaviviruses, several novel flaviviruses were latterly
discovered: Nounane in Cote d’Ivoire [19], T’Ho virus in
Mexico [20], Lammi virus in Finnland [21], and Duck
tembusu virus in China [22]. In contrast to mosquito-only
flaviviruses, these novel flaviviruses were shown to be
phylogenetically related to human pathogenic flaviviruses.
The clinical diagnosis of flavivirus infections is not un-
ambiguous due to unspecific symptoms varying from
mild, febrile illness to viral hemorrhagic fever. Many of
these viruses have a common transmission vector and
can co-circulate in the same area. All these factors make
a precise identification of the pathogen difficult.
Today most diagnostic laboratories use serological
assays for flavivirus testing. These tests are commonly
based on the enzyme-linked immunosorbent assay
(ELISA) and detect virus-specific IgM and IgG anti-
bodies. Antibodies are undetectable prior to 5–7 days
after onset of infection which hampers the usefulness of
the serological methods. Molecular techniques, in con-
trast, can be used already in the acute phase and are
known to be rapid, highly specific and sensitive.Since the early 1990s, several group-specific and gen-
eric molecular assays for detection of flaviviruses have
been developed as reviewed previously [23-25]. A num-
ber of attempts to detect several flaviviruses in a single
reverse transcription-polymerase chain reaction (RT-
PCR) assay have been made [26]. These assays vary in
the selected target region, assay format and detection
method. The highly conserved NS3 and NS5 genes have
been used predominantly for flavivirus testing, mainly as
nested, hemi-nested RT-PCR or SYBR green real-time
PCR, without using a probe for sequence verification.
The aim of this study was to develop a rapid, sensitive
and reliable TaqMan probe-based quantitative RT-PCR
(qRT-PCR) assay for simultaneous detection of several
flaviviruses, using the conserved NS5 gene region. The
introduction of Locked-Nucleic Acid (LNA) bases in the
probe increases robustness, specificity and sensitivity of
the assay and has been shown to allow quantification of
the viral load.
Results
Design and optimization of Pan-Flavi assay
Primers from publication [26-28] were aligned against
genomic sequences of all flaviviruses deposited in the
NCBI database to verify their flavivirus-generic amplifi-
cation capacity. Degenerate primers were selected based
on these published sequences, but modified in order to
increase the spectrum of flaviviruses included. As alter-
native approach individual specific flavivirus species-
specific primers were combined to avoid unspecificity
due to base combinations contained in the degenerate
primers not matching exisiting viral sequences. In par-
ticular we used 17 forward and 15 reverse primers and
another four reverse primers targeting different
locations. Testing of the primer mix with viral RNA
revealed that the performance of the primer mixes was
not improved compared to the results obtained with the
degenerate primers. Also for the probes we tested 22 in-
dividual flavivirus-specific sequences covering all known
sequence variants at the binding site and established
mixtures yielding comparable threshold cycle (Ct) values
for all virus species tested, but the signal level was sig-
nificant lower than for degenerate LNA-probes (data not
shown). In conclusion, neither the set of individual
primers nor the set of probes improved the detection
limit nor the range of viruses detected and we continued
the evaluation with the degenerate set of primers
combined with one of the three LNA-probes.
In total, six combinations assembled from two degen-
erate primer sets (Flavi all S & Flavi all AS1 and Flavi all
S & Flavi all AS2) and three probes (Flavi all probe 1,
Flavi all probe 2 and Flavi all probe 3) were tested using
RNA from flaviviruses and other viruses to check the
performance of these Pan-Flavi assays. Combinations
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Best results among these six combinations were obtained
with Flavi all S, Flavi all AS2 primers and Flavi all probe
3, but detection of DENV type 4 was insufficient. Ana-
lysis by gel electrophoresis revealed missing amplifica-
tion, except a faint band for primer combination Flavi all
S and AS1, correlating to a low signal and very late Ct
value (Table 1).
To overcome this deficit the combination Flavi all S/
AS2/probe 3 was supplemented with an additional
DEN4 F primer and all tests were repeated. DENV type
4 was now detectable with Ct values similar to the spe-
cific assay. The additional DEN4 F primer had no influ-
ence on the detection of all other flaviviruses tested
(Table 2). Evaluation of the Pan-Flavi assay was
performed using primers Flavi all S/DEN4 F and Flavi all
AS2. Changing primers to Flavi all S/Flavi all S2/ Flavi
all AS4 allowed to detect also Nounane virus (Table 3),
without changing specificity and sensitivity of Pan-Flavi
assay for the other viruses (data not shown).Table 1 Comparison of designed two degenerate primer sets
six combinations for detection of the different flavivirus RNA
Sample
No
Virus Ct value obtained through test
S/AS1/probe1 S/AS1/probe2 S
1 DENV-1 31.50 17.57
2 DENV-2 22.69 22.21
3 DENV-3 No Ct 21.25
4 DENV-4 No Ct 35.50
5 JEV 20.40 21.63
6 RSSEV 27.69 29.38
7 TBEV K23 17.68 21.81
8 TBEV Louping ill 26.00 28.75
9 Usutu virus 25.63 33.96
10 WNV Uganda 30.22 30.27
11 WNV Israel 21.76 21.83
12 SLEV 25.85 26.95
13 YFV 17D 19.82 22.48
14 YFV Asibi 23.71 26.98
15 YFV Brasil 21.35 23.73
16 YFV Ivory Coast 21.35 23.98
18 Chikungunya virus No Ct No Ct
19 RVFV No Ct No Ct
20 Sindbis virus No Ct No Ct
21 H1N1 Influenza A No Ct No Ct
22 H5N1 Influenza A No Ct No Ct
17 Negative control No Ct No Ct
DENV: Dengue virus, JEV: Japanese encephalitis virus, RSSEV: Russian spring-summer
SLEV: Saint Louis encephalitis virus, RVFV: Rift valley fever virus, YFV: Yellow fever vir
S: Flavi all S, AS1: Falvi all AS1, AS2: Flavi all AS2, probe1: Flavi all probe 1, probe 2:Specificity evaluation of the Pan-Flavi assay
The specificity of the final version of the Pan-Flavi assay
was tested using a panel of mosquito- and tick-borne
flaviviruses, one insect-only novel flavivirus and one
flavivirus with unknown vector, one virus of the
Bunyaviridae family, three of the Togaviridae family and
three of the Orthomyxoviridae family. Viral RNA of
thirty different flaviviruses was detected, verifying the
broad range specificity. However, one insect-only novel
flavivirus was not detected. Neither non-flaviviruses nor
negative controls resulted in signals, demonstrating the
absence of cross-reactivity of the Pan-Flavi assay with
non-flaviviruses (Tables 2 and 3).
Sensitivity evaluation of the Pan-Flavi assay
To determine the linearity of the assay, 10-fold serial
dilutions of the standard plasmid were tested. The Pan-
Flavi assay was shown to be linear over a range of 5
log10 copies. Limit of detection is at least 10 copies/reac-
tion of standard plasmid (Figure 1).and three probes containing wobble and LNA bases in
ing the combination of Flavi all degenerate primers and probe
/AS1/probe3 S/AS2/probe1 S/AS2/probe2 S/AS2/probe3
15.66 27.95 17.84 15.61
19.76 22.27 22.19 19.92
19.14 No Ct 20.63 18.57
35.48 No Ct No Ct No Ct
20.93 18.99 19.98 19.27
27.31 24.67 26.13 23.81
16.99 16.73 18.63 16.32
23.78 22.13 24.8 21.22
25.91 22.96 30.3 23.48
30.68 28.46 28.45 28.26
20.78 20.06 21.68 19.8
25.57 24.41 24.90 23.49
18.41 20.03 22.12 18.92
22.82 24.17 26.83 23.53
20.48 21.75 23.82 21.43
20.36 21.47 23.94 21.44
No Ct No Ct No Ct No Ct
No Ct No Ct No Ct No Ct
No Ct No Ct No Ct No Ct
No Ct No Ct No Ct No Ct
No Ct No Ct No Ct No Ct
No Ct No Ct No Ct No Ct
encephalitis virus, WNV: West Nile virus, TBEV: Tick-borne encephalitis virus,
us.
Flavi all probe 2, probe 3: Flavi all probe 3.
Table 2 Representative results of the Pan-Flavi assay to detect different flaviviruses, and its comparison with flavivirus
species-specific assays















DENV-1 ATCC VR-344 15.64 0.02 2.0 × 109 15.93 0.03 4.6 × 109 [29]
DENV-2 ATCC VR-345 20.76 0.20 6.6 × 107 18.77 0.11 6.7 × 108
DENV-3 ATCC VR-1256 19.36 0.01 1.7 × 108 20.30 0.01 2.4 × 108
DENV-4 ATCC VR-1257 16.33 0.19 1.3 × 109 16.18 0.29 3.9 × 109
YFV 17D X03700 19.17 0.17 1.9 × 108 20.51 0.17 5.6 × 108 [30]
YFV ASIBI RKI reference
strain
23.73 0.05 9.1 × 106 23.72 0.28 4.7 × 107
YFV Brazil RKI reference
strain
21.18 0.07 5.0 × 107 22.50 0.10 1.2 × 108
YFV Ivory Cost RKI reference
strain
21.44 0.21 4.2 × 107 21.29 0.05 3.1 × 108
WNV Uganda AY532665,
lineage 1
28.74 0.06 3.2 × 105 26.83 0.27 3.4 × 106 [31]
WNV Israel lineage 2 19.81 0.15 1.2 × 108 19.86 0.01 4.0 × 108
TBEV K23 AF091010 16.33 0.03 1.3 × 109 16.78 0.14 2.1 × 108 [32]
RSSEV RKI reference
strain





20.59 0.22 7.4 × 107 20.43 0.06 2.0 × 107
JEV ATCC SA14-14-2 19.36 0.01 2.4 × 108 16.73 0.01 7.7 × 108 In house
assay
GC: genome copies, Ct: threshold cycle, SD: standard deviation.
DENV: Dengue virus, JEV: Japanese encephalitis virus, RSSEV: Russian spring-summer encephalitis virus, WNV: West Nile virus, TBEV: Tick-borne encephalitis virus,
YFV: Yellow fever virus.
*Pan-Flavi assay was performed using Flavi-all S, Flavi all AS2, DEN4 F primer and Flavi all probe3 mix.
#The same amount of RNA (5 μl) was applied to both pan-Flavi assay and virus species-specific one-step qRT-PCR assays.
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PCR. The sensitivity of the Pan-Flavi assay to detect viral
RNA was compared to three virus species-specific one-
step qRT-PCR assays for DENV, TBEV and YFV, all
assays could be thus compared in one run. The RNA
stocks of DENV-1, YFV strain 17D and TBEV strain K23
were quantified by virus species-specific qRT-PCR as
described previously [29,30,32]. Then, 10-fold serial dilu-
tion of the RNA was prepared from quantified stocks to
cover a range of 101 to 107 genome copies/reaction. The
detection limit of Pan-Flavi assay was determined using
these pre-quantified RNA dilutions. Detection limit of
the Pan-Flavi assay was 100 genome copies for YFV
17D, 10 genome copies for DENV-1 and 10 genome
copies for TBEV K23 (Table 4).
Comparison of the Pan-Flavi assay with virus
species-specific qRT-PCR
The same amounts of RNA (5μl) from DENV, WNV,
YFV, TBEV and JEV were detected quantitatively by
using virus species-specific qRT-PCR assays, and theresults were compared with those obtained by the Pan-
Flavi assay for these viruses (Table 2). All four serotypes
of DENVs were detected by the Pan-Flavi assay, with
almost identical Ct values and GC/ml; although for
DENV the Pan-Flavi assay showed delayed Ct values
corresponding to one log dilution. For all YFV isolates
tested the results were similar to those with the YFV-
specific assay. Also WNV lineage 2 gave the same results
as the WNV-specific assay, while the Ct values for
lineage 1 virus were delayed. All three subtypes of TBEV
were detected by both the Pan-Flavi assay and a TBEV-
specific assay. The Ct values and genome copies/ml
determined by both methods were identical except for
RSSEV. For the detection of JEV, the Pan-Flavi assay had
half a log lower sensitivity compared to the JEV-specific
assay. WNV- and JEV-specific assays were performed in
a two-step format which could explain their higher sen-
sitivity compared to the Pan-Flavi assay.
In summary, the performance of the Pan-Flavi assay
was comparable to virus species-specific assays except
for minor differences for some strains of flaviviruses.
Table 3 Performance of the Pan-Flavi assay to detect different flaviviruses. Five μl of viral RNA extracted from virus cell culture supernatant were applied to
both pan-Flavi assay and RT-PCR
Virus Virus
abbreviation
Strain/Reference Pan-flavi assay RT-PCR *
Ct value Confirmation by gel
Flaviviridae
St. Louis Encephalitis virus SLEV ATCC VR-1265 22.19 N.d.
Usutu virus USUV AY453411 22.48 N.d.
Kunjin virus KUNV PI.France 24.97 N.d.
Kedougou virus KEDV ArD 14701 29.62 Positive
Koutango virus KOUV AnD 5443 30.29 Positive
Spondweni virus SPOV SA Ar 94 26.02 Negative
Uganda S virus UGSV ArD 109325 29.48 Positive
Wesselsbron WESSV ArB 4177 24.73 Positive
Zika virus ZIKV PI, Senegal 22.45 Positive
Sepik virus SEPV MK 7148 16.77 Positive
Dakar bat virus DBV AnD 249 32.57 Positive
Yaounade virus YAOV ArY 276/68 17.52 Positive
Bouboui virus BOUV ArB 490 31.88 Negative
Saboya virus SABV AnD 4600 27.50 Negative
Nounane virus# NOUV B3 isolate No ct N.d.
Bunya viridae
Rift valley fever virus RVFV RKI No ct N.d.
Togaviridae
Chikungunya virus LR 2006 No ct N.d.
Chikungunya virus ST05,African isolate No ct N.d.
Sindbis virus RKI No ct N.d.
Influneza virus
H1N1 Hamburg A/Hamburg/04/2009 H1N1 No ct N.d.
H1N1 California A/California/04/2009 H1N1 No ct N.d.
H5N1 A/dk/Germany R603/06 H5N1 No ct N.d.
N.d.: not done, Ct: threshold cycle, * RNA of African flaviviruses were detected using reference method described previously [33].# Nounane virus was detected using final optimized primer sets Flavi all S/Flavi all S2/













Figure 1 Standard curve constructed using ten-fold serial dilution of standard plasmid containing NS5 gene of yellow fever virus.
The detection thresholds (Ct values) are plotted against the log of known standard plasmid (pYFV) copy numbers.
Patel et al. Virology Journal 2013, 10:58 Page 6 of 11
http://www.virologyj.com/content/10/1/58Discussion
The ongoing emergence of flaviviruses poses major pub-
lic health concerns worldwide. Techniques used for mo-
lecular testing and surveillance of flaviviruses should be
able to detect and identify a wide range of flavivirus spe-
cies rapidly, with a high level of specificity and sensitiv-
ity. For this purpose, an LNA probe-based qRT-PCR
(Pan-Flavi assay) for detection of RNA of various
flaviviruses was developed. We tested several important
human-pathogenic flaviviruses to demonstrate the ability
to detect relevant members of the flavivirus genus. The
Pan-Flavi assay was also tested with other viruses, in
particular phleboviruses, alphaviruses and influenza
viruses, to determine absence of cross-reactivity.
In recent years, generic approaches targeting highly
conserved NS3 and NS5 genes have been described for
the detection of flaviviruses as summarized previously
[24,26]. These methods were predominantly in the for-
mat of nested RT-PCR or SYBR green qRT-PCR whichTable 4 Test of sensitivity of Pan-Flavi assay with pre-quantif
Quantity (Genome copies/reaction) Ct values for DENV-1
1 × 107 16.8
1 × 106 20.5
1 × 105 23.4
1 × 104 27.4
1 × 103 30.2
1 × 102 37.1
1 × 101 39.7
GC: genome copies, Ct: threshold cycle.
YFV: Yellow fever virus, TBE: Tick-borne encephalitis virus, DENV: Dengue virus.required post-amplification methods such as sequencing
or melting temperature analysis to verify the result.
In general, these methods have shown variable or
lower sensitivity than species-specific approaches when
evaluated during EQA exercises for the molecular diag-
nosis of different flavivirus [29,34]. Only in some cases
assays were comparable to those from the species-
specific methods [27].
In the past 10 years, the primer sets targeting a
conserved region of NS5 have been developed and
optimized for a broad detection of flaviviruses. This ap-
proach was not only useful to detect known flaviviruses,
but has also led to discovery of novel flaviviruses
[18,35,36].
For the novel Pan-Flavi assay, the degenerate primer
sequences share the conserved NS5 region (Figure 2)
targeted by the previous published primers (Figure 3).
These primers exhibited good efficiency in detecting a
broad range of common and exotic flaviviruses (Tables 2ied viral RNA dilutions








Figure 2 Sequence alignment of primers and probe with 26 flaviviruses conserved region of NS5 gene. + Symbol under oligonucleotides
indicates position of locked nucleotides.
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Nounane virus. The alignment for the Flavi all S primer
revealed mismatches at 6th and 8th position from the
30-end which would have been rated as non-critical
(Figure 2). However, only addition of DEN4 F primer
improved the assay for DENV type 4 (Tables 1 and 2).
Remarkably, the 3rd position from 30-end mismatch in
the reverse primer Flavi all AS2 for YFV, DENV type 2
and Usutu virus did not have any impact as these three
viruses were detected well by Pan-Flavi assay (Figure 2).
These results underline that the in-silico analysis
provides only a limited prediction for the primer specifi-
city, which still requires to be confirmed by laboratory
testing. Designing of a single probe for detection of all
flaviviruses is challenging because of the genetic diversity
and the restricted length of conserved regions. One ap-
proach is the use of oligonucleotide mixtures covering
many target sequence variants, which was applied for
detection of DENV and Crimean-Congo Hemorrhagic
fever virus (CCHF) [37,38]. Other approaches to design
broad range probes are the use of a short conserved se-
quence in combination of minor groove binding (MGB)
or LNA modifications [39,40]. First, we used 22 specific
probes for flaviviruses generic detection, but the amplifi-
cation signals were insufficient. To overcome this
problem, probes with LNA bases were designed for the
Pan-Flavi assay. Major advantages of LNA probes in
comparison to other real-time PCR formats are the
shorter probe length, stability, increased sensitivity, spe-
cificity and quenching efficiency which have been
demonstrated by many studies [30,41-45]. One of three
designed and tested LNA-based probes (Flavi all probe)
successfully targeted a broad spectrum of different
flaviviruses. The signal for detection of YFV and DENV
type 4 were optimized by adding small fractions of
specific probes (Table 5).
At present, RT-PCR in nested or hemi-nested format
is used most frequently. It requires sequencing for the
identification of viruses and needs approximately one
day for experimentation. In addition, this carries a highrisk of contamination caused by open handling of PCR
products, increasing the potential for false positives. In
contrast, the Pan-Flavi assay presented here requires
only some 50 minutes for specific and sensitive detection
of several flaviviruses in one reaction. The detection sen-
sitivity of YFV, DENV, TBEV, JEV and WNV, using the
described Pan-Flavi assay, was close to or as good as the
species-specific qRT-PCR assays. These differences may
have resulted from deviant reactions conditions, enzyme
kits and instruments, which were used as published or
in-house established, and it is to mention, that WNV
and JEV assays were performed in a two-step PCR which
is known to be more sensitive than the one-step proced-
ure [46].
The sensitivity of the Pan-Flavi assay to detect RNA
was demonstrated by using 10-fold serial dilutions of
viral RNA from DENV-1, YFV and TBEV. The assay was
able to detect 10–100 viral RNA copies per reaction, de-
pending on the respective flavivirus. The assay allows
the quantification of flavivirus RNA by use of standard
plasmids or standardised in-vitro RNA, providing infor-
mation regarding viral load and can be easily established
in other laboratories. Therefore, the Pan-Flavi assay
could be used to confirm the presence of flaviviruses in
a sample without post amplification steps or comple-
ment species-specific flavivirus assays. The amplicon
length is about 260 bp, which is sufficient to distinguish
and identify different the virus by (pyro) sequencing or
using for example an array.
The Pan-Flavi assay allows rapid detection of a broad
range of flaviviruses including local-endemic and exotic
species with a high level of sensitivity and is cost-
effective, making it suitable for screening of livestock
samples, monitoring viral activity, outbreak investigation
as well as surveillance studies of flaviviruses, and might
help finding and identifying novel flaviviruses. We ex-
pect that the assay can be also helpful for testing clinical
samples from patients with symptoms especially in an
early phase of infection and without knowledge about lo-
cally prevalent flaviviruses or travel history in order to
Figure 3 The published and Flavi-all primer sites in the Yellow fever 17D genome (NC 002031) with locations of genes. In dark green:
forward primer, in light green: reverse primer, in red: site of probe used in this study. The figure is prepared using Geneious pro version (5.4.3)
created by Biomatters.
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negative test will of course not prove absence of a
flavivirus infection.
Conclusions
Re-emergence of West Nile virus in Europe and con-
tinuous spread of certain flaviviruses such as dengue,
yellow fever and Japanese encephalitis viruses represent
a global danger to public health. The Pan-Flavi assay
presented here has been developed and evaluated in
comparison with flavivirus species-specific qPCR assays
to detect a broad range of flaviviruses simultaneously in
a single-tube. This assay represents a valuable tool for
the detection of flaviviruses in livestock samples, and
will support molecular diagnosis as well as surveillance
studies of various vectors and non-human hosts.
Methods
Viruses and isolation of viral RNA
All flavivirus and non-flavivirus strains listed below
were derived from cell culture and provided by the
Robert Koch Institute, Berlin, Germany. The following
inactivated and stable virus preparations were used in
this study: DENV-1 VR344 (Thai 1958); DENV-2 VR345
(TH-36 strain); DENV-3 VR216 (H87 strain); DENV-4
VR217 (H241 strain); WNV Uganda strain (AY532665);
WNV Israel (H. Bin, Sheba Medical Center, Israel),
kunjin virus (Institute Pasteur, France), usutu virus
(AY453411); JEV (ATCC SA14-14-2); Saint Louis en-
cephalitis virus (SLEV) (ATCC VR-1265); TBEV strain
K23 (AF091010); YFV strain 17D (X03700); YFV strain
ASIBI (AY640589); YFV strain Brazil; YFV strain Ivory
Coast; Russian Spring Summer Encephalitis virus(RSSEV); chikungunya virus (LR 2006); chikungunya
virus African isolate; sindbis virus; Rift Valley Fever virus
and influenza A virus subtype H5N1 (A/dk/Germany
R603/06 H5N1).
Two different standard preparations of H1N1 influ-
enza viruses (A/California/04/2009 and A/Hamburg/04/
2009) used in this study were provided by the European
Network for Diagnostics of Imported Viral Diseases
(ENIVD). RNA of Nounane virus was kindly provided by
Dr. Fabian Leendertz from NG2, Robert Koch Institute,
Berlin. RNA of eleven African flaviviruses (Table 3) were
kindly provided by Dr. Amadou A Sall and testing of
these viruses was done at Institut Pastuer Dakar,
Senegal.
Viral RNA from above described viruses was isolated
from 140 μl aliquots of cell culture supernatants, using
the QIAamp Viral Mini Kit (Qiagen, Hilden, Germany)
according to the manufacturer’s instructions. RNA was
eluted in 100 μl of elution buffer and stored at -80°C
until further use.
Primers and TaqMan probe
The flaviviral NS5 gene contains conserved regions often
used for PCR testing. Our laboratory results but also the
literature [27] revealed that the commonly used primers
[26-28] exhibit a low sensitivity and we failed to detect
rare flaviviruses such as Nounane virus. The primer
binding region were aligned against all Genbank (NCBI)
deposited flavivirus sequences including partial entries
for the NS5 region only using the MEGA5 software.
Based on the alignment, 32 primers and 22 probes
representing all known variants of flavivirus sequences
were selected to be used as mixture in one reaction (data
Table 5 Oligonucleotide sequence of primers and probes used in Pan-Flavi qRT-PCR assay
Primer & Probe Sequence Concentration Orientationa Positionb Tm (°C)
Flavi all S TACAACATgATggggAARAgAgARAA 10 pmol S 8993–9019 54.7
DEN4 F TACAACATgATgggRAAACgTgAGAA 10 pmol S 8996–9019 60.18
Flavi all AS 1 gTCCCANCCDgCKgTRTC 10 pmol AS 9236–9253 52.5
gTCCCATCCAgCKgTRTCATC 5 pmol AS 9236–9256 57.1
Flavi all AS 2 gTgTCCCAgCCNgCKgTgTCATCWgC 10 pmol AS 9232–9260 69.6
Flavi all probe 1 FAM-AARggHAgYMgNgCCA + TH + T + g + g + T-BBQ 5 pmol S 9044–9065 69–83
Flavi all probe 2 FAM-Tg + gTWYATgTggYTNg + gRgC–BBQ 5 pmol S 9062–9082 62–75
Flavi all probe 3 mix FAM-Tg + gTWYATgT + ggYTNg + gRgC—BBQc 5 pmol S 9062–9082 66-79
FAM-CCgTgCCATATggTATATgTggCTgggAgC-BBQd 0.5 pmol S 9052–9081 74.7
FAM-TTTCTggAATTTgAAgCCCTgggTTT-BBQe 0.5 pmol S 9086–9012 68
Flavi all S2 TACAACATgATgggMAAACgYgARAA 10 pmol S 8996–9019 58.2
Flavi all AS4 gTgTCCCAGCCNgCKgTRTCRTC 10 pmol S 9235–9260 64.1
Tm: temperature, Locked-Nucleic Acid bases are written as ‘ + _’, e.g., +A.
Degenerate bases: R = (A/G), W = (A/T), K = (T/G), Y = (C/T), N = (A/G/T/C).
a S: sense orientation, AS: antisense orientation.
b YFV strain; accession no: NC 002031.
c Flavi all probe, d Flavi probe YFV, e Flavi probe DEN4.
Final Pan-Flavi assay comprise of Flavi all S, Flavi all S2 & Flavi all AS4 primer and Flavi all probe 3 mix.
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generic primer sets and three degenerate probes
containing LNA nucleotides were designed to match ‘all’
flaviviruses. LNA nucleotides contain a 20–50 bridge, in-
creasing the duplex stability, which in turn allows the
use of shorter sequence probes matching the conserved
sequence motif.Pan-Flavi qRT-PCR assay
The Pan-Flavi qRT-PCR assay (Pan-Flavi assay) was run
with the Transcriptor One-Step RT-PCR Kit (Roche
Diagnostics Mannheim, Germany) according to the
manufacturer’s instructions. In brief, 5 μl of RNA, 10
pmol of primers Flavi all sense, Flavi all antisense 2 and
DEN4 F, and a mixture of three probes (Table 5) were
added to the master mix. Optimized run conditions were
as follows: reverse transcription at 55°C for 2 min, de-
naturation at 95°C for 30 s and 45 cycles of 95°C for 10
s and 60°C for 25 s. The amplification was performed on
a Roche LightCycler 480 instrument, software version
1.5. The spectrum of the assay can be expanded by using
Flavi all S2 instead of DEN4 F primer (Table 5).
Serial dilutions of a standard (10–106 copies/μl) were
run in duplicate for quantification. Standard plasmid was
prepared by cloning the PCR product obtained from YFV
using a TOPO TA Cloning Kit (Invitrogen, Karlsruhe,
Germany) according to the manufacturer’s instructions
and quantified by spectrophotometric method.Specific qRT-PCR for different flaviviruses
Except for DENV and JEV we used published group-
specific assays for comparison.For TBEV, we used an assay targeting the NS1 gene as
described previously [32]. qRT- PCR was carried out in
one-step format on an ABI 7500 cycler (Applied
Biosystems, California, USA), using the Superscript III
Platinum OneStep qRT-PCR Kit (Invitrogen).
A WNV-specific qRT-PCR assay for detection of
lineages 1 and 2 was used to detect and quantify genome
copies (GC) of WNV as described previously [31]. qRT-
PCR was performed in two-step format on a Stratagene
MX 3000 cycler (Agilent Technologies, Santa Clara,
USA).
YFV-specific primer combination YFV FP/RP and
probe YFV LNA2 were used to detect and quantify gen-
omic RNA of YFV as described previously [30]. The
assay was performed in one-step format on the
LightCycler 480 instrument using the QuantiTect Virus
Kit (Qiagen, Hilden, Germany).
DENV-genomic RNA was tested and quantified by an
in-house qRT-PCR as described previously [29]. The
assay is a DENV group-specific assay and was carried
out in one-step format on an ABI 7500 real-time PCR
system using the AgPath-ID One-Step RT-PCR Kit. Plas-
mid standards were used for the quantification of the
DENV GE.
A JEV-specific in-house qPCR assay was used for detec-
tion and quantification of JEV GE. qPCR was performed in
two-step format on a Stratagene MX 3000 cycler. cDNA
was generated using SuperScript II (Invitrogen) and was
stored at -20°C until use. The test was performed using Plat-
inum Taq polymerase (Invitrogen) in a total volume of 25 μl
containing 5 μl of cDNA, 2 μl of 10x Reaction Mix, 4 mM
MgCl2, 300 nM of each primer (JEV9250 F: CgTCC
AAAAgCTgggATACAT and JEV9334 R: gTCCCAYC
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TAgCAggRAAgCAAgg –BBQ) and 2.5 μM of dNTPs,
using a Stratagene Mx3000 instrument and the following
conditions: 15 min at 95°C; 45 cycles of 15 s at 95°C and 30
s at 60°C. Ten-fold serial dilutions of the standard (plasmid
10–106 copies/reaction) were included in order to determine
the limit of detection.
Final protocol for extended range specificity
The pan-flavi assay was evaluated using forward primers
Flavi all S and DEN4 F, reverse primer Flavi all AS2 and
Flavi all probe 3 mix. Based on an alignment of latterly
available NS5 gene flavivirus sequences, we substituted
primer DEN4F by Flavi all S2 and Flavi all AS2 by Flavi
all AS4 to include some novel flaviviruses (Table 3).
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